We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Single-Cell RNA Sequencing Identifies Mechanisms Underlying Autoimmune Diseases

By LabMedica International staff writers
Posted on 11 Apr 2022
Print article
Image: Strands of DNA (Photo courtesy of Garvan Institute of Medical Research)
Image: Strands of DNA (Photo courtesy of Garvan Institute of Medical Research)

Two recently published studies were designed to help understand how gene expression patterns are cell-type and context specific and can explain observed variation in immune cell function among individuals. These studies also identified causal links between genome-wide analyses and expression quantitative trait loci, identifying potential mechanisms underlying autoimmune diseases.

To identify how implicated loci affect gene expression in immune cells from individuals from different populations, two research groups performed single-cell RNA sequencing of immune cells, with each study investigating hundreds of individuals and more than one million immune cells.

The studies examined both proximal (cis) and distal (trans) genetic variants affecting gene expression in 14 different immune cell types. One research group studied healthy individuals of both European and Asian descent, as well as individuals diagnosed with systemic lupus erythematosus. The other group performed a population-based study investigating how segregating alleles contribute to variation in immune function.

The studies capitalized on the Garvan Institute of Medical Research (Darlinghurst, Australia) OneK1K cohort, which consists of single-cell RNA sequencing (scRNA-seq) data from 1.27 million peripheral blood mononuclear cells (PMBCs) collected from 982 donors.

The investigators worked in the context of The Garvan-Weizmann Centre for Cellular Genomics Molecular Services, which provided state-of-the-art advanced single cell platforms. The Centre combines the expertise of the The Garvan Institute of Medical Research with that of the Weizmann Institute of Science (Rehovot, Israel). The research facility offered services in single cell Immuno-profiling, ATAC sequencing, and Multiomics (ATAC+RNA Sequencing), and its Flow Services component provided cytometry services as well as expert consultation in the field of cytometry.

Over the course of the work, the investigators developed a framework for the classification of individual cells, and by combining the scRNA-seq data with genotype data, they mapped the genetic effects on gene expression in each of 14 immune cell types and identified 26,597 independent cis–expression quantitative trait loci (eQTLs). They showed that most of these had an allelic effect on gene expression that was cell type–specific. These results replicated in two independent cohorts, one of which comprised individuals with a different ancestry to the discovery cohort. Over all loci, the discovery and replication cohorts had a concordance of allelic direction ranging from 72.2 to 98.1% across cell types. In addition, the investigators integrated genetic association data for seven common autoimmune diseases and identified significant enrichment of genetic effects operating in a cell type–specific manner.

“We analyzed the genomic profile of over one million cells from 1,000 people to identify a fingerprint linking genetic markers to diseases such as multiple sclerosis, rheumatoid arthritis, lupus, type I diabetes, spondylitis, inflammatory bowel disease, and Crohn’s disease,” said senior author Dr. Joseph Powell, director of the Garvan Institute of Medical Research. “We were able to do this using single cell sequencing, a new technology that allows us to detect subtle changes in individual cells. Some autoimmune diseases can be notoriously difficult to treat. Because of our immune system’s complexity, and how vastly it varies between individuals, we do not currently have a good understanding of why a treatment works well in some people but not in others. The greatest insight from this work will be identification of therapeutic targets and defining sub-populations of immune disease, which can then refine clinical trials to assess drug effectiveness.”

The studies were published in the April 8, 2022, online edition of the journal Science.

Related Links:
Garvan Institute of Medical Research 
Weizmann Institute of Science 

New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Progesterone Serum Assay
Progesterone ELISA Kit
New
Chlamydia Test Kit
CHLAMYTOP

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.